computational biology
Nucleome Therapeutics Looks to Use Single-Base-Pair Genome Mapping Method for Drug Discovery
Premium
The startup, which spun out of the University of Oxford, expects that the breakthrough will lead to better drug targets for autoimmune diseases.
Fresh off a $43 million fundraising round, the drug discovery-focused bioinformatics firm is validating novel drug targets and compounds with an eye toward 2023 clinical trials.
Engine Biosciences Closes $43M Series A Round
The AI-powered bioinformatics startup will use the money to launch clinical drug discovery programs in precision oncology.
In research presented at the AMIA Informatics Summit, University of Texas bioinformaticians tried a new algorithm to include epigenetic factors in predicting disease progression.
The computers are expected to provide a boost to genomics data sharing efforts and drive the creation of machine-learning tools and associated diagnostics.